2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels
Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2012.701009
Full Text
Open PDFAbstract
Available in full text
Date
July 9, 2012
Authors
Publisher
Informa UK Limited